Christoph Schwaiger

Freelance writer

Christoph is a freelance journalist focusing primarily on health, AI, and current affairs. Just after obtaining a degree in biomedical science, Schwaiger developed a passion for writing which took him out of the lab and into the world chasing stories and sources. Schwaiger is a strong believer in community service and was elected to various local and national roles over the years, mainly in organizations focused on empowering young people. He can be reached at christoph@cschwaiger.com or on LinkedIn.

Illustration of a stack of paper and tweezers editing a strand of DNA in between two glass office buildings

Gene editing

Gene Editing Patent Landscape Remains ‘Clear as Mud,’ Say Patent Attorneys

The intellectual property landscape for newer gene-editing technologies, like that for CRISPR-Cas9, remains unclear and hard to navigate.

September 4, 2024

5 min read

Christoph Schwaiger

CRISPR

Ongoing CRISPR Patent Dispute Complicates Licensing but Hasn’t Deterred Gene-Editing Investment

As the yearslong litigation over ownership of CRISPR gene editing continues, investors have forged ahead with funding the technology’s development by biopharma.

July 17, 2024

8 min read

Christoph Schwaiger

Pictured: FDA signage at its office in Washington, DC

Policy

FDA’s OTP Super Office on Track to Fill 500 Positions

Last month, the agency hired a new director for the Office of Therapeutic Products, but both leadership and support staff positions remain open.

August 8, 2023

4 min read

Christoph Schwaiger